Dyno Therapeutics is a startup developing and applying advanced technologies for AAV gene therapy. Our pioneering CapsidMap™ platform leverages artificial intelligence combined with data from next-gen DNA synthesis and DNA sequencing experiments to systematically explore the landscape of synthetic AAV capsids. By optimizing AAV capsids for in vivo delivery, our goal is to help gene therapy reach its full potential: improving today’s therapies while unlocking the ability to treat new diseases and greater numbers of patients.
Interested in learning more? Join us this week at our virtual social mixers! Click here
Read about our platform as published in Science, Nov 2019.
Dyno is located in dynamic Cambridge, MA.
Our team-defined mission is “Collective Innovation: Empowering a diverse team of the best problem-solvers to drive cutting-edge science to improve patient health”.
We recruit specifically for individuals who desire to work in the highly collaborative, dynamic world of a fast-moving startup. We are looking for bold, creative, joyful team members who are comfortable saying “I don’t know”, and who respond to a challenge by asking “how can I help?”
Genethon is a leading organization in gene therapy R&D, with a strong focus on gene therapies for neuro-muscular disorders. Combining the strengths of private enterprise, public research, patients’ needs and international collaborations, Genethon provides an exceptional environment to conduct translational research and to advance the field of gene therapy.
Genethon recruits talented post-doctoral fellows for its initiative Post-Doc. For more information on Genethon and opportunities, please visit us here.
At Pfizer, we're driven to discover the cure—driven to significantly improve the lives of everyone...everywhere. If you’re similarly driven, you’ll find there’s no better place to begin—and continue—your career than at Pfizer.
With a shared urgency and unwavering passion, Pfizer is committed to unlocking the potential of gene therapy to make breakthroughs that change patients’ lives—today and in the future. Join us and imagine the possibilities. Visit us here.
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is at the forefront of precision genetic medicine, having built a world leading pipeline for the treatment of Duchenne muscular dystrophy (DMD). The Company has expanded its portfolio to include Limb-girdle muscular dystrophy (LGMD) and central nervous system (CNS) disorders across several therapeutic modalities, including RNA, gene therapy and gene editing. For more information, please visit www.sarepta.com.
Available opportunities include:
For further information and to see all opportunities, please visit us here.
StrideBio is advancing innovative genetic medicines for devastating rare diseases and beyond. We are a unique company with talented and passionate colleagues, including co-founder and 2020 ASGCT Outstanding Achievement Award recipient Dr. Mavis Agbandje-McKenna. Our proprietary structure-inspired adeno-associated virus (AAV) vector engineering platform is creating best-in-class gene therapies with life-changing or curative potential for patients.
Yecuris Corporation is a customer focused, science driven company located just south of Portland, OR. At Yecuris, we live by our core values: Goal Oriented, Collaborative, Committed, Integrity, and Positive Attitude. We are always curious to learn and eager to take on the biggest challenges our clients throw at us.
At Biogen, our mission is clear: we are pioneers in neuroscience. The Biogen Gene Therapy Accelerator Unit is committed to the advancement of next generation genetic medicines. Our objectives include the enablement of novel genetic targets for therapeutic development and the improvement of gene therapy technologies to accelerate the discovery of safer and more effective treatments. Together, we pioneer.
Big Molecules, Small Molecules, Gene Therapy: From research and discovery to post-market clinical development, our R&D engine involves all bench and clinical research. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with rare diseases. We treat rare diseases that give us rare opportunities.
The Cedars-Sinai Biomanufacturing Center (CBC) is hiring. This brand new cGMP facility specializes in cell therapy manufacturing for human IND-enabling clinical trials. We are looking for experienced candidates and those looking to develop a career in GMP work to join our growing team.
The Dana-Farber Cancer Institute Cell Manipulation Core Facility (CMCF) performs cell manufacturing in ISO-7 cleanrooms. Services include processing of minimally manipulated and complex autologous and allogeneic products for transplantation, genetically modified stem cells for many different applications, immune effector cells including CAR-T Cells, IPS cells and other regenerative cellular products.
The FDA’s Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies regulates biological products include gene therapy, tumor vaccines, xenotransplantation, stem cells, human tissue for transplantation, combination products, bioengineered tissues and much more! Seeking a challenging career opportunity?
FUJIFILM Diosynth Biotechnologies is a world leading cGMP Contract Development and Manufacturing organization (CDMO) with over 30 years’ experience. As a world leading CDMO we combine technical leadership in cell culture, microbial fermentation and gene therapies with process development and cGMP manufacturing capabilities from our network of four global locations in North Carolina,Texas, UK and Denmark. As part of our team, you will be an active contributor in the advancement of tomorrow’s medicine. We take pride in enriching our communities, caring for our environment, and cultivating a world of opportunity for future generations. #advancingtomorrowsmedicines #partnersforlife #worldofopportunities
Founded in 1999, GENEWIZ is a global leader in R&D Genomics services. Our customers are top-tier pharmaceutical, biotechnology, academic and start-up companies, and rely on us as a full-service provider of Genomics solutions. GENEWIZ boasts a fun, collaborative environment with outstanding growth opportunities. Join our team!
Genezen Laboratories is a rapidly growing CDMO providing cell and gene therapy development and manufacturing services to biotech clients. We are addressing the growing demand for viral vectors by expanding our facility. Genezen is searching for experienced, dedicated scientists to join our team at this exciting time.
Lonza is a global leader in life sciences with more than 15,000 employees in more than 100 locations around the world. Our Houston location is the largest dedicated cell and gene facility in the world. We offer phase appropriate development services for clinical and commercial manufacturing of a wide range of cell therapy and viral vector manufacturing process in the field of CGT.
With a robust pipeline of innovative therapies and a brand new, in-house manufacturing facility for allogeneic CAR-T cells, AAV, and mRNA, Precision BioSciences is quickly becoming the employer of choice for professionals interested in developing exciting new cell and gene therapies in the Research Triangle Park, NC area.
At PTC, we look at drug discovery and development in a completely different way from big pharma companies. We use cutting-edge technologies and groundbreaking research techniques to develop drug therapies for patients living with serious and life-threatening conditions, such as rare genetic disorders and cancer. We combine our scientific backgrounds with a patient-centric treatment approach to create a wholly new way of addressing rare disease. Help us change lives every day. Join the PTC family.
Stanford Laboratory for Cell & Gene Medicine’s (LCGM) mission is to bridge the “bench to bedside” translational gap to the clinic by creating quality manufacturing processes for cell and gene therapies to treat patients with incurable disease. We are hiring in Manufacturing, Process Development, Quality Control and Quality Assurance.
Our Commitment: To be a hero for our rare disease patients. Developing new treatments for rare genetic diseases is challenging work. It takes courage, talent, and dedication. Ultragenyx is dedicated to fostering a workplace environment that keeps our team inspired. At Ultragenyx we push each other to perform at our very best, because we never lose sight of our mission – to make a difference in our patients’ lives.
Waisman Biomanufacturing offers a unique opportunity to be part of a team dedicated to the production of novel therapeutics for human clinical trials across the world. We are seeking highly motivated, independent yet team-oriented candidates with excellent multi-tasking skills and willingness to excel in a fast-paced, client-oriented, team environment.
Abstract Notifications Sent
April 6, 2020
April 28, 2020
23rd ASGCT Annual Meeting
May 12 – 15, 2020
Use the ASGCT app on your mobile device to build your schedule, read the abstracts (released on April 28), and guide your way through the Hynes Convention Center.
Hynes Convention Center
900 Boylston St.
Boston, MA 02115